Cargando…

Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine

Detalles Bibliográficos
Autores principales: Niebel, Dennis, Ralser‐Isselstein, Veronika, Jaschke, Kristel, Braegelmann, Christine, Bieber, Thomas, Wenzel, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209903/
https://www.ncbi.nlm.nih.gov/pubmed/34075664
http://dx.doi.org/10.1111/dth.15017
_version_ 1783709213873143808
author Niebel, Dennis
Ralser‐Isselstein, Veronika
Jaschke, Kristel
Braegelmann, Christine
Bieber, Thomas
Wenzel, Joerg
author_facet Niebel, Dennis
Ralser‐Isselstein, Veronika
Jaschke, Kristel
Braegelmann, Christine
Bieber, Thomas
Wenzel, Joerg
author_sort Niebel, Dennis
collection PubMed
description
format Online
Article
Text
id pubmed-8209903
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-82099032021-06-21 Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine Niebel, Dennis Ralser‐Isselstein, Veronika Jaschke, Kristel Braegelmann, Christine Bieber, Thomas Wenzel, Joerg Dermatol Ther Letters John Wiley & Sons, Inc. 2021-06-08 2021 /pmc/articles/PMC8209903/ /pubmed/34075664 http://dx.doi.org/10.1111/dth.15017 Text en © 2021 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Niebel, Dennis
Ralser‐Isselstein, Veronika
Jaschke, Kristel
Braegelmann, Christine
Bieber, Thomas
Wenzel, Joerg
Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
title Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
title_full Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
title_fullStr Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
title_full_unstemmed Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
title_short Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
title_sort exacerbation of subacute cutaneous lupus erythematosus following vaccination with bnt162b2 mrna vaccine
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209903/
https://www.ncbi.nlm.nih.gov/pubmed/34075664
http://dx.doi.org/10.1111/dth.15017
work_keys_str_mv AT niebeldennis exacerbationofsubacutecutaneouslupuserythematosusfollowingvaccinationwithbnt162b2mrnavaccine
AT ralserisselsteinveronika exacerbationofsubacutecutaneouslupuserythematosusfollowingvaccinationwithbnt162b2mrnavaccine
AT jaschkekristel exacerbationofsubacutecutaneouslupuserythematosusfollowingvaccinationwithbnt162b2mrnavaccine
AT braegelmannchristine exacerbationofsubacutecutaneouslupuserythematosusfollowingvaccinationwithbnt162b2mrnavaccine
AT bieberthomas exacerbationofsubacutecutaneouslupuserythematosusfollowingvaccinationwithbnt162b2mrnavaccine
AT wenzeljoerg exacerbationofsubacutecutaneouslupuserythematosusfollowingvaccinationwithbnt162b2mrnavaccine